Neoadjuvant AGS-003 Immunotherapy in Patients With Localized Kidney Cancer
Phase of Trial: Phase II
Latest Information Update: 25 Apr 2017
At a glance
- Drugs Rocapuldencel-T (Primary)
- Indications Renal cell carcinoma
- Focus Biomarker; Pharmacodynamics
- 19 Apr 2017 Planned primary completion date changed from 14 Apr 2017 to 14 Jul 2017.
- 11 Feb 2015 Planned primary completion date changed from 1 Apr 2015 to 1 Apr 2017 as reported by ClinicalTrials.gov record.
- 15 Oct 2014 Status changed from 'not yet recruiting' to 'recruiting' as reported by ClinicalTrials.gov record.